Allergan Plc Stock Current Valuation
Valuation analysis of Allergan Plc helps investors to measure Allergan Plc's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Allergan Plc Company Current Valuation Analysis
Allergan Plc's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Allergan Plc Current Valuation | 81.41 B |
Most of Allergan Plc's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allergan Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Allergan Plc has a Current Valuation of 81.41 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current valuation for all United States stocks is significantly lower than that of the firm.
Allergan Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allergan Plc's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allergan Plc could also be used in its relative valuation, which is a method of valuing Allergan Plc by comparing valuation metrics of similar companies.Allergan Plc is currently under evaluation in current valuation category among its peers.
Allergan Fundamentals
Return On Equity | -0.0913 | |||
Return On Asset | -0.0564 | |||
Profit Margin | (0) % | |||
Operating Margin | 6.84 % | |||
Current Valuation | 81.41 B | |||
Shares Outstanding | 328.1 M | |||
Shares Owned By Insiders | 0.16 % | |||
Shares Owned By Institutions | 98.25 % | |||
Number Of Shares Shorted | 15.01 M | |||
Price To Earning | 24.00 X | |||
Price To Book | 1.07 X | |||
Price To Sales | 3.95 X | |||
Revenue | 15.82 B | |||
Gross Profit | 13.65 B | |||
EBITDA | 7.11 B | |||
Net Income | (9.25 B) | |||
Cash And Equivalents | 4.56 B | |||
Cash Per Share | 13.88 X | |||
Total Debt | 23.08 B | |||
Debt To Equity | 39.40 % | |||
Current Ratio | 1.00 X | |||
Book Value Per Share | 161.90 X | |||
Cash Flow From Operations | 6.47 B | |||
Short Ratio | 3.22 X | |||
Earnings Per Share | (27.98) X | |||
Price To Earnings To Growth | 3.66 X | |||
Number Of Employees | 17.4 K | |||
Beta | 1.2 | |||
Market Capitalization | 63.66 B | |||
Total Asset | 135.58 B | |||
Retained Earnings | 1.02 B | |||
Working Capital | 287.1 M | |||
Current Asset | 8.58 B | |||
Current Liabilities | 8.29 B | |||
Z Score | 1.2 | |||
Last Dividend Paid | 0.74 |
Pair Trading with Allergan Plc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allergan Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allergan Plc will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Allergan Stock
If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |